Radiation-Protective Agents
"Radiation-Protective Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.
| Descriptor ID |
D011837
|
| MeSH Number(s) |
D27.505.696.706.776 D27.720.799.763
|
| Concept/Terms |
Radiation-Protective Agents- Radiation-Protective Agents
- Radiation Protectants
- Protectants, Radiation
- Radioprotective Drugs
- Drugs, Radioprotective
- Radiation-Protective Drugs
- Drugs, Radiation-Protective
- Radiation Protective Drugs
- Radioprotective Agents
- Agents, Radioprotective
- Agents, Radiation-Protective
- Agents, Radiation Protective
- Radiation Protective Agents
- Protective Agents, Radiation
Radiation-Protective Effect- Radiation-Protective Effect
- Effect, Radiation-Protective
- Radiation Protective Effect
- Radiation-Protective Effects
- Effects, Radiation-Protective
- Radiation Protective Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Protective Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Protective Agents".
This graph shows the total number of publications written about "Radiation-Protective Agents" by people in this website by year, and whether "Radiation-Protective Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 7 | 2 | 9 |
| 2005 | 6 | 1 | 7 |
| 2006 | 2 | 1 | 3 |
| 2007 | 2 | 3 | 5 |
| 2008 | 2 | 2 | 4 |
| 2009 | 3 | 0 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 6 | 1 | 7 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 2 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiation-Protective Agents" by people in Profiles.
-
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019 05 01; 79(9):2327-2338.
-
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation. Sci Rep. 2019 02 13; 9(1):1949.
-
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 01 01; 125(1):18-44.
-
Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine. Radiat Res. 2018 05; 189(5):490-496.
-
Radioprotection With Amifostine Enhances Bone Strength and Regeneration and Bony Union in a Rat Model of Mandibular Distraction Osteogenesis. Ann Plast Surg. 2018 Feb; 80(2):176-180.
-
Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight. Aerosp Med Hum Perform. 2017 Jul 01; 88(7):665-676.
-
Reducing radiation-induced gastrointestinal toxicity - the role of the PHD/HIF axis. J Clin Invest. 2016 10 03; 126(10):3708-3715.
-
Amifostine Treatment Mitigates the Damaging Effects of Radiation on Distraction Osteogenesis in the Murine Mandible. Ann Plast Surg. 2016 Aug; 77(2):164-8.
-
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4560-9.
-
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res. 2014 Aug; 23(6):1841-58.